RELAPSED OR REFRACTORY B CELL NON HODGKIN LYMPHOMA
Clinical trials for RELAPSED OR REFRACTORY B CELL NON HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED OR REFRACTORY B CELL NON HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for RELAPSED OR REFRACTORY B CELL NON HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial offers hope for lymphoma patients out of options
Disease control Recruiting nowThis study is testing an oral drug called pemigatinib for adults with specific types of B-cell non-Hodgkin lymphoma that have returned or stopped responding to at least two prior treatments. The main goal is to see if the drug can shrink tumors and control the cancer. It is for p…
Matched conditions: RELAPSED OR REFRACTORY B CELL NON HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: University of Utah • Aim: Disease control
Last updated Apr 04, 2026 06:35 UTC
-
New drug cocktail tested for Tough-to-Treat lymphomas
Disease control Recruiting nowThis early-stage study is testing a combination of three medications (tazemetostat, zanubrutinib, and an anti-CD20 antibody) for adults with certain slow-growing B-cell lymphomas that have returned or not responded to prior treatment. The main goal is to find the highest safe dos…
Matched conditions: RELAPSED OR REFRACTORY B CELL NON HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: University of Utah • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New hope for kids with aggressive blood cancers: experimental immune cell therapy trial opens
Disease control Recruiting nowThis study is testing an experimental treatment called Obe-cel for children and teenagers whose B-cell leukemia or lymphoma has returned or not responded to standard treatments. Doctors will collect the patient's own immune cells, genetically modify them to better target cancer c…
Matched conditions: RELAPSED OR REFRACTORY B CELL NON HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: Autolus Limited • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New hope for tough lymphomas: first patients test experimental drug
Disease control Recruiting nowThis is the first time a new drug called YK012 is being tested in people. The study aims to find a safe dose and see if it helps patients with B-cell non-Hodgkin lymphoma that has come back or hasn't responded to other treatments. Researchers will enroll about 48 adults to check …
Matched conditions: RELAPSED OR REFRACTORY B CELL NON HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: Excyte Biopharma Ltd • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
First-in-Human cancer drug trial seeks to tame tough lymphoma
Disease control Recruiting nowThis is the first study to test a new immunotherapy drug called MK-1045 in people. The goal is to find a safe dose and see if it can help patients with B-cell non-Hodgkin lymphoma that has come back or stopped responding to other treatments. Researchers will give the drug to abou…
Matched conditions: RELAPSED OR REFRACTORY B CELL NON HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: MSD R&D (China) Co., Ltd. • Aim: Disease control
Last updated Mar 02, 2026 15:28 UTC